Connecticut Children's Medical Center
connecticutchildrens.orgLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
59
Active
18
Phase 3
0
Total enrollment
7,420
Pipeline matrix
Showing 3 of 3 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Marcaine 0.25 % Injectable Solution | — | — | — | — | — | 1 | |
| Saline | — | — | — | — | — | 1 | |
| Anti-TNF therapy | — | — | — | — | — | 1 |
Next readouts
- 2026-04-01
- 2028-07-01
Top conditions
- Sickle Cell Disease6
- Pain4
- Asthma3
- Bronchiolitis3
- Inflammatory Bowel Disease2
- Pain, Chronic2
- Status Asthmaticus2
- Pediatric Cancer2
Frequently asked questions about Connecticut Children's Medical Center
- How many clinical trials does Connecticut Children's Medical Center have on ClinicalTrials.gov?
- Connecticut Children's Medical Center is listed as the lead sponsor on 59 clinical trials in ClinicalTrials.gov, 18 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Connecticut Children's Medical Center's trials are in Phase 3?
- 0 of Connecticut Children's Medical Center's trials are in Phase 3, spread across 3 active drug programs.
- What therapeutic areas does Connecticut Children's Medical Center focus on?
- Connecticut Children's Medical Center's most-studied conditions on ClinicalTrials.gov are Sickle Cell Disease, Pain, Asthma, Bronchiolitis, Inflammatory Bowel Disease.
- When are Connecticut Children's Medical Center's next clinical trial readouts?
- Connecticut Children's Medical Center has 2 upcoming primary-completion readouts tracked here; the soonest is “Subpectoral Bupivacaine for Pain Management in Adolescent Reduction Mammaplasty”, expected around 2026-04-01.